Back to WELLINGTON MANAGEMENT GROUP LLPBBOT
BBOT3 quarters
Position history for WELLINGTON MANAGEMENT GROUP LLP's holdings in BRIDGEBIO ONCOLOGY THERAPEUT
WELLINGTON MANAGEMENT GROUP LLP holds 2.8M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $25.2M as of 2026-Q1. The position was decreased (-3.0% shares). BBOT represents 0.0% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.
Current Value
$25.2M
Current Shares
2.8M
Total Value Change
-$9.1M
Total Shares Change
-142,915
Quarter-by-Quarter History
Other major holders of BBOT: Alphabet Inc., CITADEL ADVISORS LLC, BlackRock, Inc.